O totoxicity and otoprotection present exciting new opportunities for audiologic practice and research. Through understanding the underlying mechanisms of ototoxic hearing loss, we have the very real possibility of developing new drugs in the near future that either do not have ototoxicity as a side effect or work specifically to prevent ototoxicity as a side effect of other drugs. The mechanisms of ototoxic damage and protection can be complex but some general concepts apply.
Redox couples: Any pair of both oxidized and reduced forms of the same compound is called a redox couple. Redox couples can be classified by their strength as measured relative to a "standard reduction potential" of the half-reaction. Powerful oxidants attract electrons. Powerful reductants provide electrons.
Electron Transport Chains: Throughout metabolic systems, there are stepwise paths from strong reductants to strong antioxidants, controlling the redox process for metabolic requirements. These stepwise paths via the intermediate electron carriers are called electron transport chains.
Types of Reactive Oxygen Species (ROS): HO • is the hydroxyl free radical (HFR). O2
• is the superoxide radical anion. HO2 • is the hydroperoxyl radical. H2O2 is hydrogen peroxide. Generally, the most damaging ROS is the hydroxyl free radical, which is extremely reactive and has an extremely short half-life. It reacts with almost any compound, including deoxyribonucleic acid (DNA), lipids, proteins, and carbohydrates. These reactions can produce many cytotoxins.
ROS Damage: ROS can damage biologically critical macromolecules such as DNA, proteins, and lipids. DNA damage can underlie mutations, cancers and cell death. Proteins can fragment, cross-link, or aggregate. Free radicals can target polyunsaturated fatty acids in cell membranes and lipoproteins. Chains of lipid peroxides may form and disrupt cell membrane function. Lipid peroxidation is particularly important because cell membranes comprise a lipid bilayer. Thus lipid peroxidation can cause cell damage and dysfunction or death. ROS damage has been implicated not only in ototoxic and noise-induced hearing loss but also stroke and cardiovascular diseases, arthritis, cancer, and many neurodegenerative disorders. ROS damage may also underlie the aging process.
Sources of Free Radicals:
Free radicals are constantly produced, even during normal metabolism such as in mitochondrial electron transport. However, damage occurs when free radical generation exceeds the capability of the antioxidant systems to control or detoxify them. This imbalance can occur by increasing ROS levels or by deactivating antioxidant systems. A number of factors can increase ROS levels, including inflammation, cigarette smoke, radiation, drugs such as cisplatin and aminoglycosides, and cochlear noise exposure. Antioxidant systems can be deactivated when certain enzyme systems are inactivated; antioxidants, such as free radical scavengers, are not present in sufficient amounts; or major antioxidant systems such as the glutathione pathway are inactivated. For example, poor nutrition can diminish many natural antioxidant systems.
Utility of oxidative damage:
As previously mentioned, ROS generation is a part of normal metabolic processes and is not necessarily damaging in a controlled, balanced physiologic system. However, even oxidative toxicity can be critical to maintaining health. ROS toxicity is an essential part of immune system defenses. Phagocytic white blood cells employ high levels of superoxides and other oxidants to kill unwanted microorganisms in a process called "respiratory burst".
Reducing antioxidants can sometimes increase the efficacy of certain drugs, particularly those drugs that act, at least in part, by ROS processes. Thus, in developing protective agents, such as otoprotective agents for ototoxic drugs, you have to ensure that you are not reducing the drugs therapeutic efficacy simultaneously.
The following are some major antioxidant mechanisms. There are a multitude of antioxidants and free radical scavengers, but the following are some of the major factors.
Enzymes: An enzyme is a complex protein substance, produced in living cells. Enzymes cause or accelerate other chemical reactions within an organism but are not altered themselves in the process. Basically, enzymes are organic catalysts. Two major enzymes involved in detoxifying ROS are:
Superoxide dismutase which converts O2 • the superoxide radical anion, into oxygen O2 and hydrogen peroxide H2O2. Catalase then converts the hydrogen peroxide H2O2 into water (H2O) and oxygen (O2).
The glutathione pathway: Glutathione is a tripeptide comprising glutamate, cysteine, and glycine, which is present in almost all mammalian tissues and, to a lesser degree, in plasma. Glutathione helps eliminate xenobiotics (foreign drugs or substances) and serves as a major antioxidant. Glutathione can be present in the reduced (GSH) or oxidized (GSSG or glutathione disulfide) form. In normal systems, 99 percent of glutathione is in the GSH form. High levels of GSSG (oxidized form) relative to GSH can be a sign of oxidative stress. Sometimes the GSSG/GSH ratio is used as a quantitative measure of oxidative stress in a system.
The glutathione pathway is an important antioxidant pathway -in fact, an essential part of antioxidant defenses -with GSH being an important reductant. GSH protects cells from oxidative damage by donating a hydrogen atom from the thiol group of the cysteine residue. The hydrogen atom can be donated to most carbon, nitrogen or oxygencentered radicals, thus stabilizing them and rendering them less reactive. The major enzymes of the glutathione pathway are glutathione peroxidase, which oxidizes GSH to GSSG, and glutathione reductase, which reduces GSSG back to GSH. GSH is then again available to serve as an antioxidant. The glutathione transferases (GSTs) catalyze the conjugation of GSH with electrophilic chemical compounds and thus serve as a major defense system against electrophiles, which can be cytotoxic, mutagenic and carcinogenic. GSTs can also play a role in drug resistance.
Altered GSH homeostasis has been implicated in many different pathological conditions. Decreased GSH can increase the therapeutic efficacy of some drugs but can increase side effects. In other words, it can increase the drug's toxicity for all cells, not just the drug's target tissues (e.g., tumor cells).
